Special Issues
Table of Content

Advances in Tissue Engineering and Regenerative Medicine

Submission Deadline: 31 December 2025 View: 475 Submit to Special Issue

Guest Editors

Dr. Sharun Khan

Email: sharun.khan@northwestern.edu

Affiliation: Center for Regenerative Nanomedicine, Northwestern University, Chicago, IL 60611, USA

Homepage:

Research Interests: Regenerative Medicine, Wound Healing, Tissue Engineering, Bone Regeneration, Stem Cell Therapy, Stem Cell Biology, Mesenchymal Stem Cells, Animal Models, Hydrogel, Cartilage Regeneration, Stromal Vascular Fraction, Platelet-Rich Plasma

图片1.png


Summary

The significance of Tissue engineering and regenerative medicine (TERM) lies in its potential to address the limitations of traditional medical treatments, offering promising alternatives for conditions that currently lack effective therapies. Recent advancements have led to the development of lab-grown tissues and organs, such as blood vessels, which hold immense potential for clinical applications. Central to these innovations are the molecular mechanisms that govern cellular behavior, differentiation, and interaction.


Aim and Scope
This Special Issue aims to showcase cutting-edge research and developments in TERM, providing a platform for experts worldwide to share their findings. We welcome contributions that explore novel approaches, technologies, and methodologies to advance the understanding and application of molecular mechanisms at the cellular biology level.


The scope includes, but is not limited to:
· Innovative tissue engineering techniques
· Advancements in regenerative therapies
· Development and application of biomaterials
· Stem cell research and its applications
· Clinical trials and translational studies


Suggested Themes

We encourage submissions on a variety of themes within TERM, including:

1. Bioinspired Materials for Regenerative Medicine: Design, synthesis, characterization, and application of bioinspired materials, with an emphasis on their biocompatibility and interaction with cellular signaling pathways.

2. Advances in 3D Bioprinting: Innovations in three-dimensional bioprinting technologies that incorporate molecular cues for enhanced tissue and organ fabrication.

3. Stem Cell Therapies: Exploration of stem cells in regenerative medicine, focusing on molecular mechanisms governing MSC isolation, differentiation, and their roles in tissue regeneration.

4. Clinical Applications and Trials: Studies focusing on translating TERM research into clinical settings, emphasizing how molecular insights drive recent innovations and emerging trends.

5. Emerging Trends in Regenerative Medicine: Identification and analysis of new developments in regenerative medicine, highlighting molecular innovations reshaping diagnostic, therapeutic, and preventive practices.


This Special Issue aims to provide a comprehensive platform for discussing cutting-edge research and practices in TERM while prominently highlighting the molecular mechanisms that underpin cellular biology, thereby contributing to improved healthcare delivery, enhanced patient outcomes, and overall community well-being.


Keywords

tissue engineering, regenerative medicine, stem cell therapy, biomaterials, 3D bioprinting, scaffold design, tissue regeneration, organ transplantation, cellular therapies, extracellular vesicles

Published Papers


  • Open Access

    REVIEW

    Role of Platelet Derivatives and Their Therapeutic Potential in Wound Healing

    Sanggu Kim, Seongmo Yang, Soochong Kim
    BIOCELL, Vol.49, No.12, pp. 2335-2364, 2025, DOI:10.32604/biocell.2025.072418
    (This article belongs to the Special Issue: Advances in Tissue Engineering and Regenerative Medicine)
    Abstract Regenerative medicine has attracted increasing attention across diverse organs, including the skin, musculoskeletal tissues, eye, and nervous system, where structural repair is limited. Among these, skin wound care is particularly urgent and challenging because diabetic ulcers, pressure injuries, and severe burns often resist standard dressings, debridement, and revascularization, resulting in infection, amputation, and high costs. Platelet-rich plasma (PRP) has gained value because platelets release coordinated growth factors and cytokines (e.g., platelet-derived growth factor, transforming growth factor-β, vascular endothelial growth factor, epidermal growth factor, fibroblast growth factor, and insulin-like growth factor-1) that modulate hemostasis, inflammation, angiogenesis,… More >

Share Link